Hemoglobin Levels in Pulmonary Tuberculosis Patients who Consuming Anti-Tuberculosis Medicine

Authors

  • Supriati Wila Djami Poltekkes Kemenkes Kupang
  • Agustina W Djuma Poltekkes Kemenkes Kupang
  • Marni Tangkelangi Poltekkes Kemenkes Kupang

Keywords:

anti-tuberculosis drugs, hemoglobin, lungs, mycobacterium tuberculosis, tuberculosis

Abstract

Tuberculosis (TB) is a lung infection characterized by pulmonary infiltrates and the formation of caseous granulomas, fibrosis, and cavities. TB is the second leading cause of death from infectious diseases worldwide, after the human immunodeficiency virus (HIV). To reduce the death rate due to TB, the government carried out the Find Drugs Until Heal program with examinations for 6-9 months to kill the Mycobacterium tuberculosis bacteria with anti-tuberculosis drugs, namely Isoniazid, Rifampicin, Ethambutanol, Streptomycin, and Pyrazinamide. Anti Tuberculosis Drugs can cause fever, nausea and hematological reactions such as anemia, agranulocytosis, eosinophilia and thrombocytopenia. The research method used is descriptive using a cross sectional approach, namely to find out the description of hemoglobin levels in Tuberculosis patients who consume Anti Tuberculosis Drugs. 60%, in the productive age of 31-50 years with a percentage of 67% and occurs in patients with two months of treatment, namely initial or intensive treatment with a percentage of 87%.

References

Bashir, B.A., Abdallah, S.A., dan Mohamedani, A.A. (2015) Anemia Among Patients With Pulmonary Tuberkulosis In Port Sudan, Easten Sudan, International Journal of Recent Scientific Research, 6(5), Pp. 4128-4131. http://recentscientific.com/anemia-among-patients-pulmonary-tuberculosis-port-sudan-eastern-sudan

Dinas Kesehatan. (2018). Profil Kesehatan Provinsi Nusa Tenggara Timur 2018. https://dinkes.nttprov.go.id/index.php/publikasi/publikasi-data-dan-informasi

Dinas Kesehatan. (2018). Profil Kesehatan Kota Kupang 2018. https://dinkes-kotakupang.web.id/bank-data/category/1-profil-kesehatan.html?download=36:profil-kesehatan-tahun-2018

Fauziah, I., dan Siahaan, G.E. (2014). Kadar Hemoglobin (Hb) Penderita Tb Paru Dalam Masa Terapi OAT (obat anti tuberkulosis) di Puskesmas Haji Abdul Halim Hasan Binjai, Jurnal Biologi Lingkungan, Industri, & Kesehatan, 1(1): 13-17. https://ojs.uma.ac.id/index.php/biolink/article/view/14

Gunadi, V.I.R., Mewo, Y.M., dan Tiho, M. (2016). Gambaran Kadar Hemoglobin Pada Pekerja Bangunan,Jurnal E-Biomedik, Vol., 4(2). https://ejournal.unsrat.ac.id/index.php/ebiomedik/article/view/14604

Gafar, N. (2017). Gambaran Kadar Hemoglobin Darah Pada Penderita TB Paru Di Puskesmas Poasia Kota Kendari, Karya Tulis Ilmiah, Jurusan Analis Kesehatan, Kendari. http://repository.poltekkes-kdi.ac.id/278/.

Istiantoro, Y.H., dan Setiabudy, R. (2012). Farmakologi dan Terapi. Fakultas Kedokteran Universitas Indonesia, Journal Of Recent Scientific Research, 6(5), Jakarta.

Kementrian Kesehatan RI. (2013). Program Penyembuhan Kematian Akibat Tuberkulosis. Pusat Promosi Kesehatan Kemenkes Republik Indonesia. Jakarta. http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No._67_ttg_Penanggulangan_Tuberkolosis_.pdf. Kementrian Kesehatan RI. (2018). Infodatin Toss Tuberkulosis, https://pusdatin.kemkes.go.id/articel/view/18101500001/infodatin-tuberculosis-2018.html.

Lasut, N.M., Rotty, L.W.A., dan Poliii, E.B.I. (2014). Gambaran Kadar Hemoglobin dan Trombosit pada Pasien Tuberkulosis Paru di RSUP Prof. Dr. Kandau Manado Periode Januari 2014-desember 2014, Jurnal Kedokteran Klinik 1(3): 5-10, Fakultas Kedokteran Universitas Sam Ratu Langi, Manado. https://ejournal.unsrat.ac.id/index.php/eclinic/article/view/11025.

Permana, A. (2020). Gambaran Kadar Hemoglobin dan Leukosit Pada PenderitaTB Paru Dengan Lamanya Terapi OAT (Obat Anti Tuberkulosis) di Rumah Sakit Islam Jakarta Cempaka Putih, Jurnal Ilmiah Analis Kesehatan, 6(2): 136-143. http://journal.thamrin.ac.id/index.php/anakes/article/download/364/323.

Profil Kesehatan Indonesia. (2019). Data dan Informasi Profil Kesehatan Indonesia Tahun2019. https://pusdatin.kemkes.go.id/folder/view/01/structure-publikasi-data-pusat-data-dan-informasi.html.

Sari, D.I., Yuniar, Y., dan Syaripuddin, M. (2014). Studi Monitoring Efek Samping Obat Anti Tuberkulosis FDC Kategori 1 di Provinsi Banten Dan Provinsi Jawa Barat, Jurnal litbangkes. vol.24: 28-35. http://ejournal.litbang.kemkes.go.id/index.php/MPK/article/download/3484/3446

World Health Organization (WHO). (2009). WHO Global Tuberculosis Report. https://scholar.google.co.id/scholar?q=World+Health+Organization+(WHO),+2009,+WHO+Global+Tuberculosis+Report.&hl=id&as_sdt=0&as_vis=1&oi=scholart

Widoyono. (2008). Penyakit Tropis Epidemiologi Penularan, Pencegahan & Pemberantasannya. Jakarta.

Downloads

Published

2022-10-14

How to Cite

Djami, S. W., Djuma, A. W., & Tangkelangi, M. (2022). Hemoglobin Levels in Pulmonary Tuberculosis Patients who Consuming Anti-Tuberculosis Medicine. Jurnal Ilmiah Permas: Jurnal Ilmiah STIKES Kendal, 12(4), 1101–1106. Retrieved from https://journal2.stikeskendal.ac.id/index.php/PSKM/article/view/485